Marketable Securities - InterCure Ltd

12 Months Ended

Dec. 31, 2021

Marketable Securities - InterCure Ltd [Abstract]

MARKETABLE SECURITIES – InterCure Ltd

NOTE 6: MARKETABLE SECURITIES – InterCure Ltd

a. All marketable securities held by the Company constitute Level 1 financial instruments, as defined in IFRS 13 - “Fair Value Measurement”. Level 1 inputs are quoted prices (unadjusted) in active markets for identical assets or liabilities that the entity can access at the measurement date.

b. The Company holds the following financial instruments:

	December 31,
	2021		2020
	U.S. dollars in thousands
Marketable securities - InterCure Ltd		3,158		2,411

The entire investment in marketable securities is classified as a financial asset at fair value through profit or loss. As of December 31, 2021 the Company holds approximately 1.11% of InterCure Ltd’s shares (the shares are traded at the Tel-Aviv Stock Exchange - “TASE” and at the Nasdaq Capital Market - “Nasdaq”).

c. Changes in marketable securities for the years ended December 31, 2021, 2020 and 2019, were as follows:

	December 31,
	2021		2020		2019
	U.S. dollars in thousands
Fair value opening balance		2,411		2,273		2,847
Changes in fair value during the year		747		138		(574	)
Fair value closing balance		3,158		2,411		2,273